Emory University Global Blood Therapeutics, Inc. Transaction History

Emory University

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $1.78 Million - $2.28 Million	-39,349 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$52.6 - $63.29 $337,797 - $406,448	-6,422 Reduced 14.03%	39,349 $2.07 Million
Q1 2019 May 09, 2019	SELL	$39.99 - $53.48 $674,711 - $902,314	-16,872 Reduced 26.93%	45,771 $2.42 Million
Q4 2018 Feb 12, 2019	BUY	$31.54 - $46.67 $1.98 Million - $2.92 Million	62,643 New	62,643 $2.57 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

Stay updated on Emory University with notifications on news.